ARCHIVES

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

HHS Carcinogen Guidelines For Labs Could Apply To Other

May 30, 1980

Abstracts of Papers From ASCO Meeting

April 14, 1978

NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants

February 14, 1992

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987

How NCI Plans To Spend Funds In FY 1980

July 14, 1978

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005